51 Stocks Moving In Monday's Mid-Day Session

Gainers

• Genocea Biosciences, Inc. GNCA rose 56 percent to $8.75 after the company presented results from its ongoing Phase 1/2a trial for GEN-009, the company's lead neoantigen vaccine candidate, at ASCO 2019.
• ARCA biopharma, Inc. ABIO shares climbed 40.3 percent to $8.12.
• Mirati Therapeutics, Inc. MRTX rose 34.1 percent to $90.92 in sympathy with Amgen after the company presented the first clinical data evaluating a KRASG12C inhibitor, AMG 510, at ASCO 2019.
• Sellas Life Sciences Group Inc SLS gained 25.6 percent to $0.6320 after the company announced breast cancer data from its study of Nelipepimut-S plus Trastuzumab at ASCO 2019.
• Cypress Semiconductor Corporation CY rose 24.7 percent to $22.23. Cypress Semiconductor confirmed it has agreed to be acquired by Infineon Technologies AG IFNNY for $23.85 per share in cash, translating to an enterprise value of 9 billion euros, or $10.05 billion.
• Eyegate Pharmaceuticals Inc EYEG shares rose 20.5 percent to $0.3036 after the company received FDA approval to initiate its photorefractive keratectomy pivotal study.
• Spirit MTA REIT SMTA gained 16.4 percent to $8.18. Spirit MTA REIT agreed to sell a net lease portfolio to Hospitality Properties Trust for $2.4 billion in cash.
• Heat Biologics Inc HTBX shares rose 15.8 percent to $0.9493 after the company announced interim Phase 2 lung cancer data showing that its HS-110 demonstrated clinical activity in tumor patients.
• Vical Incorporated VICL fell 14.8 percent to $0.9798 after the company announced an all-stock merger agreement with Brickell Biotech.
• El Paso Electric Company EE rose 14.3 percent to $66.53 after the company agreed to be acquired by the Infrastructure Investments Fund for $68.25 per share in cash.
• Avenue Therapeutics, Inc. ATXI gained 13.8 percent to $5.92 after the company announced its second pivotal Phase 3 trial of IV tramadol met its primary and key secondary endpoints.
• Rexahn Pharmaceuticals, Inc. RNN climbed 13.1 percent to $5.57.
• Outlook Therapeutics, Inc. OTLK rose 12.5 percent to $2.7000 after signing a manufacturing supply agreement with FUJIFILM Diosynth Biotechnologies as a part of commercialization strategy for ONS-5010.
• Nektar Therapeutics NKTRgained 12.2 percent to $35.13 in sympathy with Amgen after the company presented the first clinical data evaluating a KRASG12C inhibitor, AMG 510, at ASCO 2019.
• Dyadic International, Inc. DYAI climbed 11.9 percent to $4.98.
• Avenue Therapeutics Inc ATXI climbed 11.7 percent to $5.81 after the company announced its second pivotal Phase 3 trial of IV tramadol met its primary and key secondary endpoints.
• Huami Corporation HMI rose 11.6 percent to $8.18 after reporting a first-quarter earnings beat.
• Nektar Therapeutics NKTR shares rose 11.3 percent to $34.86 after presenting biomarker and clinical data from PIVOT-02 Phase 2 study of bempegaldesleukin with nivolumab at the ASCO Annual Meeting.
• Deciphera Pharmaceuticals, Inc. DCPH gained 10.4 percent to $25.19.
• Luckin Coffee Inc. LK shares rose 10.2 percent to $22.15 after gaining 8.65 percent on Friday.
• Iovance Biotherapeutics, Inc. IOVA gained 9.8 percent to $17.95.
• Atomera Incorporated ATOM rose 9.7 percent to $4.63.
• Conformis, Inc. CFMS climbed 9.2 percent to $3.9084.
• Compass Diversified Holdings LLC CODI gained 9.1 percent to $16.97.
• Tailored Brands, Inc. TLRD surged 7.9 percent to $5.68.
• Teva Pharmaceutical Industries Ltd TEVA rose 6.7 percent to $9.23. Oppenheimer upgraded Teva Pharmaceutical from Perform to Outperform and announced a $12 price target.
• Medigus Ltd. MDGS shares rose 4.2 percent to $2.47 after the company signed a $3 million agreement with Golden Grand for the licensing and sale of goods for Medigus Ultrasonic Surgical Endostapler system in greater China.
• Eni SpA E rose 3.3 percent to $30.94 following reports the company made an oil discovery off of the shore of Angola.
• Humana Inc. HUM rose 3.1 percent to $252.26 after the company announced it would not propose to merge with Centene.

Check out these big penny stock gainers and losers

Losers

• FTD Companies Inc FTD dipped 76.2 percent to $0.1811 after the company filed voluntary Chapter 11 petitions to facilitate the completion of strategic initiatives. The company will also be delisted from the Nasdaq.
• DelMar Pharmaceuticals Inc DMPI dipped 42.7 percent to $2.3400 after the company announced a $3.6 million registered direct offering.
• Aduro BioTech, Inc. ADRO dropped 26.5 percent to $2.3890. Aduro Biotech and Novartis presented results from ongoing Phase 1b study of STING agonist ADU-S100 (MIW815) in combination with anti-PD-1 monoclonal antibody spartalizumab (PDR001) in patients with advanced solid tumors or lymphomas at the ASCO 2019.
• Eltek Ltd. ELTK dipped 17.7 percent to $6.00.
• Support.com, Inc. SPRT dropped 17 percent to $1.85 in sympathy with Google and Amazon after the FTC and DOJ decided to put the two tech giants under antitrust oversight.
• Cyclerion Therapeutics, Inc. CYCN shares declined 17 percent to $11.58.
• Five Prime Therapeutics, Inc. FPRX dropped 14.2 percent to $7.21 after Wells Fargo downgraded the company's stock from Outperform to Market Perform and lowered the price target from $35 to $10.
• Soliton, Inc. SOLY shares tumbled 14.1 percent to $16.16.
• Flexible Solutions International Inc. FSI dropped 14 percent to $2.9748.
• TrueCar, Inc. TRUE fell 12.7 percent to $5.70 after the company reported the retirement of CEO Chip Perry.
• Celldex Therapeutics, Inc. CLDX fell 12.2 percent to $2.6700 after presenting results from the CDX-3379 clinical program at the 2019 American Society of Clinical Oncology Annual Meeting in Chicago.
• Senmiao Technology Limited AIHS dropped 11.2 percent to $4.86.
• Conn's, Inc. CONN dropped 11.1 percent to $15.95.
• Quotient Limited QTNT dipped 10.7 percent to $8.64.
• Kaixin Auto Holdings KXIN fell 10.4 percent to $2.15 after receiving notice of delisting for warrants.
• Centene Corporation CNC fell 9.1 percent to $52.49 after Humana announced it would not propose to merge with Centene.
• Natural Health Trends Corp. NHTC dropped 9.1 percent to $9.26.
• NanoViricides Inc NNVC fell 9.1 percent to $0.2500 after the company received 'favorable' comments from the FDA regarding its pre-IND application for its lead drug candidate.
• Precipio, Inc. PRPO tumbled 8.3 percent to $4.9999.
• KBS Fashion Group Limited KBSF dropped 8 percent to $2.8542 following Q1 results.
• Bridgeline Digital, Inc. BLIN fell 6.7 percent to $3.09 after declining 16.41 percent on Friday.
• Alphabet Inc. GOOGL fell 5.6 percent to $1,044.48 after the Justice Department announced an antitrust investigation into Google.